Home>Topics>Insiders>Dr. Eric E. Schmidt, Ph.D.

Dr. Eric E. Schmidt, Ph.D.

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
  1. Baidu, Inc: Greater Than Google, Or Safer To Sell? An Algorithmic Perspective

    Headlines

    Thu, 14 Aug 2014

    sizeable - if slightly shy - asset to the company: educated in America and grudgingly applauded even by Google CEO Eric Schmidt , who calls him a "clever entrepreneur," Li has big plans for Baidu, and Complete Story »

  2. Anacor Pharmaceuticals' (ANAC) CEO Paul Berns on Q2 2014 Results - Earnings Call Transcript

    Headlines

    Thu, 7 Aug 2014

    Communications Paul Berns - CEO Vince Ippolito - EVP and Chief Commercial Officer Geoff Parker - EVP and CFO Analysts Eric Schmidt - Cowen and Company Presentation Operator Good day, ladies and gentlemen and thank you for standing by and welcome to

  3. Auxilium Pharmaceuticals' (AUXL) CEO Adrian Adams on Q2 2014 Results - Earnings Call Transcript

    Headlines

    Thu, 7 Aug 2014

    Executive Vice President of Sales & Marketing Analysts Michael J. Yee - RBC Capital Markets, LLC, Research Division Eric Schmidt - Cowen and Company, LLC, Research Division Gary Jay Nachman - Goldman Sachs Group Inc., Research Division Annabel

  4. Regulus Therapeutics' (RGLS) CEO Kleanthis Xanthopoulos on Q2 2014 Results - Earnings Call Transcript

    Headlines

    Wed, 6 Aug 2014

    Officer Neil W. Gibson – Chief Scientific Officer Dan Chevallard – Vice President, Finance and Accounting Analysts Eric Schmidt – Cowen & Company Mark – Needham & Company Bill Tanner – FBR Capital Markets Christopher James – Brinson Patrick Securities

  5. ChemoCentryx's (CCXI) Tom Schall on Q2 2014 Results - Earnings Call Transcript

    Headlines

    Tue, 5 Aug 2014

    ET Executives Susan Kanaya - SVP, Finance, CFO and Secretary Tom Schall - Chairman, President and CEO Analysts Eric Schmidt - Cowen and Company Brian Klein – Stifel Nicolaus Michael Ulz – JP Morgan Presentation Operator Welcome to the ChemoCentryx

  6. Sunesis Pharmaceuticals' (SNSS) CEO Daniel Swisher on Q2 2014 Results - Earnings Call Transcript

    Headlines

    Tue, 5 Aug 2014

    Executive Vice President of Development Joseph I. DePinto - Chief Commercial Officer and Executive Vice President Analysts Eric Schmidt - Cowen and Company, LLC, Research Division Adnan S. Butt - RBC Capital Markets, LLC, Research Division Andrew R

  7. ISIS Pharmaceuticals' (ISIS) CEO Stan Crooke on Q2 2014 Results - Earnings Call Transcript

    Headlines

    Mon, 4 Aug 2014

    Verma - Stifel Nicolaus Nicholas Abbott - BMO Capital Markets Chad Messer - Needham & Company Whitney Ijem - JPMorgan Eric Schmidt - Cowen and Company Lisa Zhang - Goldman Sachs Presentation Operator Welcome to the Isis Pharmaceuticals’ Second Quarter

  8. Momenta's (MNTA) CEO Craig Wheeler on Q2 2014 Results - Earnings Call Transcript

    Headlines

    Thu, 31 Jul 2014

    Financial Officer Analysts Gary Nachman - Goldman Sachs Sumant Kulkarni - Bank of America David Risinger - Morgan Stanley Eric Schmidt - Cowen and Company Jason Gerberry - Leerink Partners Liav Abraham - Citi Presentation Operator Good day, ladies and gentlemen

  9. Incyte's (INCY) CEO Hervé Hoppenot on Q2 2014 Results - Earnings Call Transcript

    Headlines

    Thu, 31 Jul 2014

    President and CEO Jim Daly - CCO Dave Hastings - CFO Rich Levy - CMO and Head of Drug Development Reid Huber - CSO Analysts Eric Schmidt - Cowen & Company Josh Schimmer - Piper Jaffray Matt Roden - UBS Whitney Ijem - JPMorgan Chase & Co. Steve Byrne

  10. Amgen (AMGN) CEO Bob Bradway on Q2 2014 Results - Earnings Call Transcript

    Headlines

    Tue, 29 Jul 2014

    Commercial Operations Sean Harper - Head of R&D Analysts Matthew Harrison - Morgan Stanley Robyn Karnauskas - Deutsche Bank Eric Schmidt - Cowen & Company Terence Flynn - Goldman Sachs Geoffrey Porges - Sanford C. Bernstein Josh Schimmer - Piper Jaffray Yaron

« Prev123Next »
Content Partners